<DOC>
	<DOCNO>NCT00271856</DOCNO>
	<brief_summary>To examine effect Mindfulness-Based Stress Reduction ( MBSR ) education group HIV ( Human Immunodeficiency Syndrome ) infection . Key outcomes include CD4 viral load , stress hormone , depression quality life .</brief_summary>
	<brief_title>Staying Well : A Clinical Trial Mindfulness-Based Stress Reduction Education Groups HIV</brief_title>
	<detailed_description>Stress depression associate rapid loss CD4 cell HIV infection . Interventions slow advance HIV infection delay introduction antiretroviral therapy ( ART ) could make important contribution HIV management develop develop world . We conduct 330 person randomize , control clinical trial MBSR person HIV-1 infection CD4 T-lymphocyte count &gt; 250 cells/Âµm antiretroviral therapy . Participants randomize 1:1 distribution either MBSR intervention education group control attention social interaction aspect MBSR . Participants evaluate 0 , 3 , 6 12 month . Key outcome measure 12 month include difference CD4 T cell count , HIV viral load , perceive stress , depression , positive affect . We also examine whether MBSR associate change neuroendocrine function ( autonomic nervous system activity , cortisol secretion ) alteration immune function may serve intermediate step neuroendocrine effect MBSR CD4 T cell count , change T cell activation . A subset 90 participant study additional detail use structured laboratory stress challenge .</detailed_description>
	<criteria>HIV+ Viral Load &gt; 100 CD4 TCells &gt; 250 Not Antiretroviral therapy ( ART ) Ability Speak English Stable address/living situation Inability provide inform consent Use ART within past 120 day Any substance abuse , mental health medical condition opinion Principal Investigator ( PI ) would make difficult potential participant participate intervention Plans start ART next 12 month Previous MBSR training and/or current practice Current use use past 6 month ( mo . ) chemotherapy immunomodulator drug , include oral steroid plan start next 12 mo . Initiation new class psychiatric medication past 2 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>Meditation</keyword>
	<keyword>Stress</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Complementary Therapies</keyword>
	<keyword>MBSR</keyword>
	<keyword>Not ART medication</keyword>
</DOC>